Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R McCready

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Breast Journal|January 18, 2006
Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysisJudith-Anne W Chapman, H Lavina A Lickley, Maureen E Trudeau, et al.
Breast Cancer Research and Treatment|August 31, 2012
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant studySaroj Niraula, Ryan J O Dowling, Marguerite Ennis, et al.
Breast Cancer Research and Treatment|January 25, 2005
Prognostic factors affecting the natural history of node-negative breast cancerMaureen E Trudeau, Kathleen I Pritchard, Judy-Anne W Chapman, et al.
The Breast Journal|July 20, 2006
Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging systemHarriette J Kahn, Wedad M Hanna, Judy-Anne W Chapman, et al.
Annals of Surgical Oncology|December 10, 2016
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) MastectomyKelly K Hunt, David M Euhus, Judy C Boughey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast RadiotherapyFei-Fei Liu, Wei Shi, Susan J Done, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancerShelley B Bull, Hilmi Ozcelik, Dushanthi Pinnaduwage, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2020
Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and RadiationDana Keilty, Shirin Nezafat Namini, Monali Swain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJean-Francois Boileau, Brigitte Poirier, Mark Basik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2018
Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in MelanomaAras Toker, Linh T Nguyen, Simone C Stone, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Breast Journal|January 18, 2006
Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysisJudith-Anne W Chapman, H Lavina A Lickley, Maureen E Trudeau, et al.
Breast Cancer Research and Treatment|August 31, 2012
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant studySaroj Niraula, Ryan J O Dowling, Marguerite Ennis, et al.
Breast Cancer Research and Treatment|January 25, 2005
Prognostic factors affecting the natural history of node-negative breast cancerMaureen E Trudeau, Kathleen I Pritchard, Judy-Anne W Chapman, et al.
The Breast Journal|July 20, 2006
Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging systemHarriette J Kahn, Wedad M Hanna, Judy-Anne W Chapman, et al.
Annals of Surgical Oncology|December 10, 2016
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) MastectomyKelly K Hunt, David M Euhus, Judy C Boughey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast RadiotherapyFei-Fei Liu, Wei Shi, Susan J Done, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancerShelley B Bull, Hilmi Ozcelik, Dushanthi Pinnaduwage, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2020
Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and RadiationDana Keilty, Shirin Nezafat Namini, Monali Swain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJean-Francois Boileau, Brigitte Poirier, Mark Basik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2018
Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in MelanomaAras Toker, Linh T Nguyen, Simone C Stone, et al.
Pageof 8